Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination

A Tóthpál1, K Laub1, S Kardos1

  • 1Institute of Medical Microbiology,Semmelweis University,Budapest,Hungary.

Epidemiology and Infection
|November 10, 2015
PubMed

Insights

Pneumococcal conjugate vaccines (PCV) led to a rise in disease-causing serotype 19A in Hungarian children. This highly resistant strain dominated in areas with high PCV use, despite stable overall carriage rates.

Area of Science:

  • Microbiology
  • Epidemiology
  • Vaccinology

Background:

  • Global shifts in pneumococcal serotypes followed conjugate vaccine introduction.
  • Serotype 19A emerged as a significant concern due to its invasive potential and antibiotic resistance.

Purpose of the Study:

  • To investigate the prevalence of Streptococcus pneumoniae serotype 19A in Hungarian children.
  • To analyze serotype distribution changes in relation to pneumococcal conjugate vaccine (PCV) uptake.

Main Methods:

  • Screening of 2262 children aged 3-6 years for pneumococcal carriage via nasal swabs.
  • Categorization of children into low and high PCV vaccination rate groups.
  • Analysis of serotype distribution, antibiotic resistance (macrolides, penicillin), and genotyping of 19A isolates.

Main Results:

  • Overall pneumococcal carriage rate remained stable (32.9%) across groups and time.
  • Serotype 19A prevalence increased more than eightfold in the high PCV uptake group.
  • Nearly all 19A isolates exhibited high-level macrolide resistance and elevated penicillin minimum inhibitory concentrations.
  • Genotyping indicated that the dominant 19A strains were distinct from the previous Hungary19A-6 PMEN clone.

Conclusions:

  • PCV widespread use in Hungary correlated with a significant increase in serotype 19A prevalence.
  • The emerging 19A strains possess concerning antibiotic resistance profiles.
  • Serotype 19A became the dominant strain in high PCV uptake areas, highlighting a serotype replacement phenomenon.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
53.8K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.6K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38